Keyphrases
Breast Cancer
61%
Advanced or Metastatic
45%
Treatment of Women
45%
Trastuzumab
45%
HER2-positive Breast Cancer
45%
Copy number
45%
Locally Advanced
45%
Liver Metastasis
45%
Lapatinib
45%
Brain Metastases
45%
Irinotecan
45%
Topoisomerase
45%
Clinical Outcomes
45%
Phase II Study
45%
Inoperable Patients
45%
Radiofrequency Ablation
45%
Metastatic Breast Cancer
35%
HER2-targeted Therapy
27%
Response Rate
25%
Median Survival
22%
Local Recurrence Rate
22%
Clinical Benefit
19%
Blood-brain Barrier
18%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Metastatic Breast Cancer
58%
Liver Metastasis
45%
Trastuzumab
45%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
45%
Irinotecan
45%
DNA Topoisomerase
45%
Recurrence Risk
45%
Chemotherapy
31%
Biological Marker
25%
Prospective Study
22%
Systemic Treatment
22%
Diseases
22%
Blood-Brain Barrier
18%
Metastasis
15%
Medicine and Dentistry
Breast Cancer
90%
Liver Metastasis
45%
Radiofrequency Ablation
45%
Topoisomerase
45%
Irinotecan
45%
Metastatic Breast Cancer
35%
Biological Marker
25%
Recurrence Risk
22%
